3728 Jinke Rd, Building 1, West Wing, Shanghai, China
info@tyligand.com
2026
- Tyligand Bioscience Presents the Latest Clinical Data of KRAS G12D Inhibitor TSN1611 at the 2026 ASCO GI
- Tyligand Bioscience Presents the Latest Data for TSN1611 in KRAS G12D-Mutated Non-Small Cell Lung Cancer at the 2026 ASCO Rapid Oral Abstract Session
- Tyligand Bioscience's KRAS G12D Inhibitor TSN1611 Selected for 2026 ASCO Rapid Oral Abstract Session